| LP309050-5 | Angioplasty^W contrast IA | COMPONENT | 3 |
| LP309051-3 | Diameter.anterior-posterior^W expiration | COMPONENT | 1 |
| LP309052-1 | Diameter.anterior-posterior^W inspiration | COMPONENT | 1 |
| LP309053-9 | Gastric emptying time^post 100 mg sodium acetate PO | COMPONENT | 1 |
| LP309054-7 | Gastric emptying time^post 100 mg sodium octanoate PO | COMPONENT | 1 |
| LP309055-4 | Guidance additional day for infusion of thrombolytic^W thrombolytic via catheter | COMPONENT | 1 |
| LP309056-2 | Guidance additional day for infusion of thrombolytic^W thrombolytic via chest tube | COMPONENT | 1 |
| LP309057-0 | Guidance additional for angioplasty^W contrast IA | COMPONENT | 1 |
| LP309058-8 | Guidance additional for angioplasty^W contrast IV | COMPONENT | 1 |
| LP309059-6 | Guidance final day for infusion of thrombolytic^W thrombolytic via catheter | COMPONENT | 1 |
| LP30906-9 | Poikilocytosis | COMPONENT | 3 |
| LP309060-4 | Guidance for angioplasty^W contrast | COMPONENT | 6 |
| LP309061-2 | Guidance for angioplasty^W contrast IA | COMPONENT | 22 |
| LP309062-0 | Guidance for angioplasty^W contrast IV | COMPONENT | 3 |
| LP309063-8 | Guidance for aspiration or biopsy^W contrast IV | COMPONENT | 1 |
| LP309064-6 | Guidance for atherectomy^W contrast | COMPONENT | 4 |
| LP309065-3 | Guidance for atherectomy^W contrast IA | COMPONENT | 2 |
| LP309066-1 | Guidance for atherectomy^W contrast IV | COMPONENT | 5 |
| LP309067-9 | Guidance for balloon dilatation^W contrast | COMPONENT | 1 |
| LP309068-7 | Guidance for biopsy^W contrast IV | COMPONENT | 1 |
| LP309069-5 | Guidance for biopsy^WO contrast | COMPONENT | 1 |
| LP309070-3 | Guidance for change of central venous catheter^W contrast IV | COMPONENT | 4 |
| LP309071-1 | Guidance for change of dialysis catheter^W contrast IV | COMPONENT | 1 |
| LP309072-9 | Guidance for change of percutaneous tube^W contrast | COMPONENT | 1 |
| LP309073-7 | Guidance for change of tube^W contrast | COMPONENT | 1 |
| LP309074-5 | Guidance for chemoembolization for tumor^W chemotherapy IA+W embolic agent IA | COMPONENT | 1 |
| LP309076-0 | Guidance for removal of central venous catheter^W contrast IV | COMPONENT | 1 |
| LP309077-8 | Guidance for dilation of stricture+placement of stent^W contrast IV | COMPONENT | 1 |
| LP309081-0 | Guidance for removal of embolus^W contrast IA | COMPONENT | 2 |
| LP309082-8 | Guidance for removal of embolus^W contrast IV | COMPONENT | 1 |
| LP309083-6 | Guidance for embolization for tumor^W embolic agent IA | COMPONENT | 2 |
| LP309084-4 | Guidance for embolization^W contrast IA | COMPONENT | 1 |
| LP309085-1 | Guidance for embolization^W embolic agent IA | COMPONENT | 1 |
| LP309086-9 | Guidance for embolization^W embolic agent IV | COMPONENT | 1 |
| LP309087-7 | Guidance for endoscopy^1.5H post contrast retrograde intrabiliary | COMPONENT | 1 |
| LP309088-5 | Guidance for endoscopy^15M post contrast retrograde intrabiliary | COMPONENT | 1 |
| LP309089-3 | Guidance for endoscopy^1H post contrast retrograde intrabiliary | COMPONENT | 1 |
| LP30909-3 | Lymphocyte proliferation Phytohemagglutinin Stimulation | COMPONENT | 4 |
| LP309090-1 | Guidance for endoscopy^2H post contrast retrograde intrabiliary | COMPONENT | 1 |
| LP309091-9 | Guidance for endoscopy^30M post contrast retrograde intrabiliary | COMPONENT | 1 |
| LP309092-7 | Guidance for endoscopy^45M post contrast retrograde intrabiliary | COMPONENT | 1 |
| LP309093-5 | Guidance for endoscopy^W contrast retrograde | COMPONENT | 3 |
| LP309094-3 | Guidance for endoscopy^WO & W contrast IV | COMPONENT | 1 |
| LP309095-0 | Guidance for endoscopy^WO contrast | COMPONENT | 1 |
| LP309096-8 | Guidance for infusion of thrombolytic^W thrombolytic via central venous catheter | COMPONENT | 1 |
| LP309097-6 | Guidance for injection^W Tc-99m MAA IA | COMPONENT | 1 |
| LP309098-4 | Guidance for localization of abscess^W radionuclide IV | COMPONENT | 3 |
| LP309099-2 | Guidance for localization of bleeding site^W radionuclide IV | COMPONENT | 1 |
| LP30910-1 | Lymphocyte proliferation Candida albicans Stimulation | COMPONENT | 2 |
| LP309100-8 | Guidance for localization of tumor multiple areas^W radionuclide IV | COMPONENT | 1 |